ADIPOQ and fatty liver disease: Given that adiponectin exerts its protective effects against liver steatosis through activating AMPK signaling pathway34 which is enhanced in Arg-II−/− mouse liver (Fig. 3B), we examined the adiponectin levels in adipose tissues, plasma and liver.